Brainlab Quentry First Online Medical Platform to Receive EuroPriSe European Data Privacy Seal

Brainlab AGBrainlab, a global leader in medical technology, today announced that it has received the EuroPriSe European Data Privacy Seal for Quentry® by Brainlab. The seal certifies that Quentry is compliant with data protection directives implemented by all European states.

Quentry enables medical professionals to share images, display the images in a web-based viewer and add comments such as medical opinions. Quentry supports clinicians throughout the referral, review, planning and treatment workflow, supporting patient data management and collaboration. Quentry is the first cloud-based medical service to receive certification from EuroPriSe.

Addressing regulations on privacy and data security for all European states, EuroPriSe certification required a rigorous, two-year evaluation process. Quentry underwent this robust audit, which improved upon and validated the platform’s technical and organizational measures and multilayered encryption technology embedded in the architecture.

Quentry employs advanced encryption and access control technologies that approximate the level of a true end-to-end encryption to the greatest extent possible. This safeguards that all sensitive medical information is protected. Data uploaded and stored on Quentry can only be accessed and viewed by authorized individuals.

"With an increasing number of worldwide data security breaches, protecting patient and user data is vital to any cloud-based medical platform," said Rainer Birkenbach, Executive Vice President. "Brainlab developers built a multi-layered encryption system, which protects all patient data against unjustified inspection - even service providers and administrators are not able to individually decrypt data. Our goal was to go above and beyond the most stringent requirements for high-level data protection that customers and government regulators demand with Quentry. We’re pleased to see our efforts rewarded by EuroPriSe."

The responsibility for the lawful processing of patient data lies with the users of the service. They are advised by Brainlab that the legitimate use of Quentry requires the collection of patients' informed consent and release from medical confidentiality and that they are obliged to verify the identity of other users in a reliable way prior to sharing medical information with them.

"Brainlab expended a great deal of effort in order to ensure the confidentiality of sensitive data," says Sebastian Meissner, Head of the EuroPriSe Certification Authority. Meissner said positive aspects of Quentry include, "comprehensive privacy hints provided to users and the ability to de-identify meta data about patients."

The EuroPriSe seal is valid for two years, and will continuously be re-evaluated when new features and functionalities are added to Quentry.

About Brainlab
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments.

Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.

Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 9,000 systems installed in about 100 countries. Brainlab employs 1,300 people in 18 offices worldwide, including 320 Research & Development engineers, who form a crucial part of the product development team.

About EuroPriSe
EuroPriSe started as an EU-funded project aimed at establishing a trans-European privacy seal. Today, EuroPriSe offers certifications for IT products, IT-based services and websites throughout the EU. A unique certification, the EuroPriSe seal assures users that their personal data are handled in accordance with European data protection laws. As the only EU-wide, independent privacy seal, EuroPriSe enables enterprises to demonstrate their compliance with European laws and regulations. EuroPriSe certifications have been awarded to businesses of all sizes, including small and medium-sized companies as well as multinational organizations such as Microsoft and SAP.

Most Popular Now

Is Your Marketing Effective for an NHS C…

How can you make sure you get the right message across to an NHS chief information officer, or chief nursing information officer? Replay this webinar with Professor Natasha Phillips, former...

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...